The evaluation of the external dose measurement of the patients treated with radioiodine therapy

Radiation Protection Dosimetry

Volumn 141, Issue 3, 2010, Pages 233-238

  Mulazimoglu, Mehmet ^a   Edis, Nurcan ^a   Tamam, Muge Oner ^a   Uyanik, Ercan ^a   Ozpacaci, Tevfik ^a  

^a OKMEYDANI TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE;

ARTICLE; FEMALE; HOSPITALIZATION; HUMAN; HYPERTHYROIDISM; MALE; METHODOLOGY; RADIATION RESPONSE; RADIOMETRY; RADIOTHERAPY; REPRODUCIBILITY; RETROSPECTIVE STUDY; RISK; THYROID TUMOR; TIME;

DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HOSPITALIZATION; HUMANS; HYPERTHYROIDISM; IODINE RADIOISOTOPES; MALE; RADIOMETRY; RADIOTHERAPY; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK; THYROID NEOPLASMS; TIME FACTORS;

EID: 77957297155     PISSN: 01448420     EISSN: None     Source Type: Journal    
DOI: 10.1093/rpd/ncq179     Document Type: Article

References (13)

1. Klerk, J. M. H. I-131 therapy: inpatient or outpatient? J. Nucl. Med., 41(11), 1876-1878 (2000).
2. Cherly, M. Culver and Howard, J. Dworkin. Radiation safety considerations for post-iodine-131 hyperthyroid therapy. J. Nucl. Med. 32, 169-173 (1991).
3. Cherly, M. Culver and Howard, J. Dworkin: Radiation safety considerations for post-iodine-131 thyroid cancer therapy. J. Nucl. Med. 33, 1402-1405 (1992).
4. Ibis, E., Wilson, C. R., Collier, D., Akansel, G., Işi{dotless}tman, A. T. and Yass, R. G. Iodine-131 contamination from thyroid cancer patients. J. Nucl. Med. 33, 2110-2115 (1992).
5. Parthasaraty, K. L. and Crawford, E. S. Treatment of thyroid carcinoma: emphasis on high-dose I-131 outpatient therapy. J. Nucl. Med. Technol. 30(4), 165-71 (2002).
6. Barington, S. F., Doherty, M. J. O., Keffle, A. G., Thomson, W. H., Moutford, P. J., Burrell, D. N., Farrel, R. J., Batcheior, S., Seed, P. and Harding, L. K. Radiation exposure of families of outpatients treated with radioiodine (iodine-131) for hyperthyroidism. Eur. J. Nucl.Med. 26(7), 686-692 (1999).
7. Barington, S. F., Doherty, M. J. O., Keffle, A. G., Thomson, W. H., Moutford, P. J., Burrell, D. N., Farrel, R. J., Batcheior, S., Seed, P. and Harding, L. K. Measurement of the internal dose to families of outpatients treated with I-131 for hyperthyroidism. Eur. J. Nucl. Med. Mol. Imaging 35, 2097-2104 (2008).
8. European Commission. Radiation protection following Iodine-131 therapy (exposures due to out-patients or discharged inpatients). Radiation Protection 97 (Luxembourg: Office for Official Publications of the European Communities) (1998).
9. Official Journal of Republic of Turkey (2000). Number 23999, Article 31.
10. Jorgensen, H. B., Hoilund-Carisen, P. F. and Nielsen, V. E. External dose rates in radioiodine treatment of bening goitre:estimation versus direct measurement: Scand. J. Clin. Lab. İnvest. 66(6), 509-516 (2006).
11. Leslie, W. D., Havvevlock, J., Palser, R. and Abrams, D. N. Large-body radiation doses following radioiodine therapy. Nucl. Med. Comm., 23, 1091-1097 (2002).
12. Tsuchimachi, S., Nakajo, M., Umanodan, T., Fukushimo, N., Shigaki, S. and Kiku, T. A. Study on the isolation period of patients with metastatic thyroid cancer treaded by 131-I according to a new guideline. Kaku Igaku 38(6), 747-754 (2001).
13. US Nuclear Regulatory Commission. US Nuclear Regulatory Commission Web site. Release of patients administered radioactive materials: 8.39. Available on http://www.nrc.gov/NRC/RG/08/08-039.html (accessed 13 March 2000).